0001209191-11-029540.txt : 20110518 0001209191-11-029540.hdr.sgml : 20110518 20110518195553 ACCESSION NUMBER: 0001209191-11-029540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110509 FILED AS OF DATE: 20110518 DATE AS OF CHANGE: 20110518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gillespie Deirdre CENTRAL INDEX KEY: 0001354737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 11856151 MAIL ADDRESS: STREET 1: 416 MARLBOROUGH STREET STREET 2: APT. 707 CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-05-09 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001354737 Gillespie Deirdre 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock 2011-05-09 4 M 0 99166 0.006 A 99166 D Common Stock 2011-05-17 4 S 0 99166 0.016 D 0 D Series C-1 Convertible Preferred 0.006 2011-05-09 4 M 0 0.595 595.00 D Common 99166 111.205 D Shares issued on conversion of Series C-1 Convertible Preferred. The Series C-1 Convertible Preferred has a face value of $1,000 per share and was convertible into Common Stock at a ratio of 166,667 shares of Common Stock per share of Series C-1 Convertible Preferred. Reflects the price following a one-time adjustment on May 7, 2011 after the Company's 100 to 1 reverse split. Exercisable date is not applicable. Expiration date is not applicable. /s/ Deirdre Y. Gillespie 2011-05-18